Download PDF
Semin Respir Crit Care Med 2003; 24(6): 639-652
DOI: 10.1055/s-2004-815660
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Non-Genetic Influences on Cystic Fibrosis Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures, and Healthcare Interventions

Michael S. Schechter
  • Department of Pediatrics, Brown University School of Medicine, Rhode Island Hospital/Hasbro Children's Hospital, Providence, Rhode Island
Further Information

Publication History

Publication Date:
15 January 2004 (online)

    Permissions and Reprints

ABSTRACT

Patients with cystic fibrosis (CF) exhibit significant variability in the course and severity of the disease, and this variability is best interpreted in the context of an interaction between genetic and nongenetic determinants. While a small number of patients with “mild” mutations in the CF transmembrane conductance regulator gene clearly have less severe disease, for the general population of patients with CF the strongest predictor of severity of clinical course appears to be socioeconomic status (SES). Low SES probably exerts an influence via the convergence of detrimental environmental influences on outcome such as environmental tobacco smoke, poor nutrition, and stress. Other important predictors that appear to be independent of SES include gender and acquisition of airway pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex. Finally, effective provision of medical interventions is an important determinant of outcome, and this is affected primarily by patient adherence (which bears a poorly defined relationship to SES), and attendance at a CF care center that utilizes a system of care that allows optimal delivery of evidence-based interventions.

KEYWORDS

Cystic fibrosis - outcome assessment (health care) - socioeconomic factors - nutritional status - psychological stress - tobacco smoke pollution - treatment refusal - quality of health care

REFERENCES

  • 1 FitzSimmons S C. The changing epidemiology of cystic fibrosis.  J Pediatr . 1993;  122 1-9
    PubMedGoogle Scholar
  • 2 Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2001 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation 2002
  • 3 Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.  Hum Genet . 1994;  93 364-368
    PubMedGoogle Scholar
  • 4 Kulczycki L L, Kostuch M, Bellanti J A. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations.  Am J Med Genet . 2003;  116A 262-267
    CrossrefPubMedGoogle Scholar
  • 5 Lester L A, Kraut J, Lloyd-Still J. et al . Delta F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population.  Pediatrics . 1994;  93 114-118
    PubMedGoogle Scholar
  • 6 Kerem E, Corey M, Kerem B S. et al . The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508).  N Engl J Med . 1990;  323 1517-1522
    PubMedGoogle Scholar
  • 7 Hubert D, Bienvenu T, Desmazes-Dufeu N. et al . Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients.  Eur Respir J . 1996;  9 2207-2214
    CrossrefPubMedGoogle Scholar
  • 8 Loubieres Y, Grenet D, Simon-Bouy B. et al . Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.  Chest . 2002;  121 73-80
    CrossrefPubMedGoogle Scholar
  • 9 Rozmahel R, Wilschanski M, Matin A. et al . Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor.  Nat Genet . 1996;  12 280-287
    PubMedGoogle Scholar
  • 10 Zielenski J. Genotype and phenotype in cystic fibrosis.  Respiration . 2000;  67 117-133
    CrossrefPubMedGoogle Scholar
  • 11 Drumm M L. Modifier genes and variation in cystic fibrosis.  Respir Res . 2001;  2 125-128
    CrossrefPubMedGoogle Scholar
  • 12 Acton J D, Wilmott R W. Phenotype of CF and the effects of possible modifier genes.  Paediatr Respir Rev . 2001;  2 332-339
    CrossrefPubMedGoogle Scholar
  • 13 Mahadeva R, Lomas D A. Secondary genetic factors in cystic fibrosis lung disease.  Thorax . 2000;  55 446
    CrossrefPubMedGoogle Scholar
  • 14 Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.  Am J Med Genet . 2002;  111 88-95
    CrossrefPubMedGoogle Scholar
  • 15 Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989.  Am J Epidemiol . 1996;  143 1007-1017
    PubMedGoogle Scholar
  • 16 Demko C A, Byard P J, Davis P B. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.  J Clin Epidemiol . 1995;  48 1041-1049
    CrossrefPubMedGoogle Scholar
  • 17 Hudson I, Phelan P D. Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis?.  Pediatr Pulmonol . 1987;  3 288-297
    PubMedGoogle Scholar
  • 18 O'Connor G T, Quinton H B, Kahn R. et al . Case-mix adjustment for evaluation of mortality in cystic fibrosis.  Pediatr Pulmonol . 2002;  33 99-105
    CrossrefPubMedGoogle Scholar
  • 19 Rosenfeld M, Davis R, FitzSimmons R, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality.  Am J Epidemiol . 1997;  145 794-803
    PubMedGoogle Scholar
  • 20 Guilbault C, Stotland P, Lachance C. et al . Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.  Immunology . 2002;  107 297-305
    CrossrefPubMedGoogle Scholar
  • 21 Allen J R, McCauley J C, Selby A M. et al . Differences in resting energy expenditure between male and female children with cystic fibrosis.  J Pediatr . 2003;  142 15-19
    CrossrefPubMedGoogle Scholar
  • 22 Stallings V A. Gender, death and cystic fibrosis: is energy expenditure a component?.  J Pediatr . 2003;  142 4-6
    CrossrefPubMedGoogle Scholar
  • 23 Jolly D L, Nolan T, Moller J, Vimpani G. The impact of poverty and disadvantage on child health.  J Paediatr Child Health . 1991;  27 203-217
    PubMedGoogle Scholar
  • 24 Mackenbach J P, Kunst A E, Cavelaars A E, Groenhof F, Geurts J J. Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health.  Lancet . 1997;  349 1655-1659
    CrossrefPubMedGoogle Scholar
  • 25 Dimissie K, Ernst P, Hanley J A, Locher U, Menzies D, Becklake M. Socioeconomic status and lung function among primary school children in Canada.  Am J Respir Crit Care Med . 1996;  153 719-723
    PubMedGoogle Scholar
  • 26 Ernst P, Demissie K, Joseph L, Locher U, Becklake M R. Socioeconomic status and indicators of asthma in children.  Am J Respir Crit Care Med . 1995;  152 570-575
    PubMedGoogle Scholar
  • 27 Halfon N, Newacheck P W. Childhood asthma and poverty; differential impacts and utilization of health services.  Pediatrics . 1993;  91 56-61
    PubMedGoogle Scholar
  • 28 Finkelstein J A, Brown R W, Schneider L C. et al . Quality of care for preschool children with asthma: the role of social factors and practice setting.  Pediatrics . 1995;  95 389-394
    PubMedGoogle Scholar
  • 29 Weiss K B. Inner-city asthma: the epidemiology of an emerging US public health concern.  Chest . 1992;  101 S362-S367
    PubMedGoogle Scholar
  • 30 Britton J. Effects of social class, sex, and region of residence on age at death from cystic fibrosis.  BMJ . 1989;  298 483-487
    PubMedGoogle Scholar
  • 31 Macpherson C, Redmond A O, Leavy A, McMullan M. A review of cystic fibrosis children born to single mothers.  Acta Paediatr . 1998;  87 397-400
    CrossrefPubMedGoogle Scholar
  • 32 Westwood A T. The prognosis of cystic fibrosis in the Western Cape region of South Africa.  J Paediatr Child Health . 1996;  32 323-326
    PubMedGoogle Scholar
  • 33 Schechter M S, Margolis P A. Relationship between socioeconomic status and disease severity in cystic fibrosis.  J Pediatr . 1998;  132 260-264
    PubMedGoogle Scholar
  • 34 Schechter M S, Shelton B J, Margolis P A, FitzSimmons S C. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.  Am J Respir Crit Care Med . 2001;  163 1331-1337
    PubMedGoogle Scholar
  • 35 O'Connor G T, Quinton H B, Kneeland T. et al . Median household income and mortality rate in cystic fibrosis.  Pediatrics . 2003;  111 e333-e339
    Google Scholar
  • 36 Wilkinson R G. Income inequality, social cohesion, and health: clarifying the theory-a reply to Muntaner and Lynch.  Int J Health Serv . 1999;  29 525-543
    PubMedGoogle Scholar
  • 37 Krieger N, Williams D R, Moss N E. Measuring social class in US public health research: concepts, methodologies, and guidelines.  Annu Rev Public Health . 1997;  18 341-378
    CrossrefPubMedGoogle Scholar
  • 38 Kennedy B P, Kawachi I, Glass R, Prothrow-Stith D. Income distribution, socioeconomic status, and self rated health in the United States: multilevel analysis.  BMJ . 1998;  317 917-921
    PubMedGoogle Scholar
  • 39 Kawachi I, Kennedy B P. Income inequality and health: pathways and mechanisms.  Health Serv Res . 1999;  34 215-227
    PubMedGoogle Scholar
  • 40 Reijneveld S A. The impact of individual and area characteristics on urban socioeconomic differences in health and smoking.  Int J Epidemiol . 1998;  27 33-40
    CrossrefPubMedGoogle Scholar
  • 41 Smith G D, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study.  BMJ . 1998;  316 1631-1635
    PubMedGoogle Scholar
  • 42 Gazmararian J A, Adams M M, Pamuk E R. Associations between measures of socioeconomic status and maternal health behavior.  Am J Prev Med . 1996;  12 108-115
    PubMedGoogle Scholar
  • 43 Davey Smith G, Hart C, Hole D. et al . Education and occupational social class: which is the more important indicator of mortality risk?.  J Epidemiol Community Health . 1998;  52 153-160
    CrossrefPubMedGoogle Scholar
  • 44 Liberatos P, Link B G, Kelsey J L. The measurement of social class in epidemiology.  Epidemiol Rev . 1988;  10 87-120
    PubMedGoogle Scholar
  • 45 Johnson N J, Sorlie P D, Backlund E. The impact of specific occupation on mortality in the US National Longitudinal Mortality Study.  Demography . 1999;  36 355-367
    PubMedGoogle Scholar
  • 46 Fein O. The influence of social class on health status: American and British research on health inequalities.  J Gen Intern Med . 1995;  10 577-586
    PubMedGoogle Scholar
  • 47 Zill N. Parental schooling and children's health.  Public Health Rep . 1996;  111 34-43
    PubMedGoogle Scholar
  • 48 Rothman K J, Greenland S. Modern Epidemiology.  2nd ed. Philadelphia: Lippincott-Raven; 1998
    Google Scholar
  • 49 Holahan J, Rowland D, Feder J, Heslam D. Explaining the recent growth in Medicaid spending.  Health Aff . 1993;  12 177-193
    PubMedGoogle Scholar
  • 50 Pincus T, Esther R, DeWalt D A, Callahan L F. Social conditions and self-management are more powerful determinants of health than access to care.  Ann Intern Med . 1998;  129 406-411
    PubMedGoogle Scholar
  • 51 Schmitzberger R, Rhomberg K, Buchele H. et al . Effects of air pollution on the respiratory tract of children.  Pediatr Pulmonol . 1993;  15 68-74
    PubMedGoogle Scholar
  • 52 Apter A J, Reisine S T, Affleck G, Barrows E, ZuWallack R L. Adherence with twice-daily dosing of inhaled steroids: socioeconomic and health-belief differences.  Am J Respir Crit Care Med . 1998;  157 1810-1817
    PubMedGoogle Scholar
  • 53 Schenker M B, Samet J M, Speizer F E. Risk factors for childhood respiratory disease: the effect of host factors and home environmental exposures.  Am Rev Respir Dis . 1983;  128 1038-1043
    PubMedGoogle Scholar
  • 54 Stoddard J J, Miller T. Impact of parental smoking on the prevalence of wheezing respiratory illness in children.  Am J Epidemiol . 1995;  141 96-102
    PubMedGoogle Scholar
  • 55 Tager I B, Ngo L, Hanrahan J P. Maternal smoking during pregnancy.  Am J Respir Crit Care Med . 1995;  152 977-983
    PubMedGoogle Scholar
  • 56 Rubin B K. Exposure of children with cystic fibrosis to environmental tobacco smoke.  N Engl J Med . 1990;  323 782-788
    PubMedGoogle Scholar
  • 57 Smyth A, O'Hea U, Williams G, Smyth R, Heaf D. Passive smoking and impaired lung function in cystic fibrosis.  Arch Dis Child . 1994;  71 353-354
    PubMedGoogle Scholar
  • 58 Kovesi T, Corey M, Levison H. Passive smoking and lung function in cystic fibrosis.  Am Rev Respir Dis . 1993;  148 1266-1271
    PubMedGoogle Scholar
  • 59 Campbell III W P, Parker R A, Roberts B T, Krishnamani M R, Phillips III A J. Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion.  J Pediatr . 1992;  120 261-264
    PubMedGoogle Scholar
  • 60 Gilljam H, Stenlund C, Ericsson-Hollsing A, Strandvik B. Passive smoking in cystic fibrosis.  Respir Med . 1990;  84 289-291
    PubMedGoogle Scholar
  • 61 Schuster M A, Franke T, Pham C B. Smoking patterns of household members and visitors in homes with children in the United States.  Arch Pediatr Adolesc Med . 2002;  156 1094-1100
    PubMedGoogle Scholar
  • 62 Butz A M, Rosenstein B J. Passive smoking among children with chronic respiratory disease.  J Asthma . 1992;  29 265-272
    PubMedGoogle Scholar
  • 63 Nelson D E, Emont S L, Brackbill R M, Cameron L L, Peddicord J, Fiore M C. Cigarette smoking prevalence by occupation in the United States: a comparison between 1978 to 1980 and 1987 to 1990.  J Occup Med . 1994;  36 516-525
    PubMedGoogle Scholar
  • 64 Haire-Joshu D, Morgan G, Fisher Jr B E. Determinants of cigarette smoking.  Clin Chest Med . 1991;  4 711-725
    PubMedGoogle Scholar
  • 65 Schechter M S. Poverty and Disease Severity in CF: Social and Biological Implications.  Pediatr Pulmonol Suppl . 1999;  119 156-157
    PubMedGoogle Scholar
  • 66 Burns J L, Gibson R L, McNamara S. et al . Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.  J Infect Dis . 2001;  183 444-452
    CrossrefPubMedGoogle Scholar
  • 67 Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa J Pediatr .  1990;  116 714-719
    PubMedGoogle Scholar
  • 68 Nixon G M, Armstrong D S, Carzino R. et al . Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.  J Pediatr . 2001;  138 699-704
    CrossrefPubMedGoogle Scholar
  • 69 Hudson V L, Wielinski C L, Regelmann W E. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years.  J Pediatr . 1993;  122 854-860
    CrossrefPubMedGoogle Scholar
  • 70 Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson R L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.  Pediatr Pulmonol . 2002;  34 91-100
    CrossrefPubMedGoogle Scholar
  • 71 Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.  Pediatr Pulmonol . 1995;  19 10-15
    PubMedGoogle Scholar
  • 72 Jones A M, Dodd M E, Doherty C J, Govan J R, Webb A K. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa Thorax .  2002;  57 924-925
    PubMedGoogle Scholar
  • 73 Henry R L, Mellis C M, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis.  Pediatr Pulmonol . 1992;  12 158-161
    CrossrefPubMedGoogle Scholar
  • 74 Johnson C, Butler S M, Konstan M W, Morgan W, Wohl M E. Factors influencing outcomes in cystic fibrosis: a center-based analysis.  Chest . 2003;  123 20-27
    CrossrefPubMedGoogle Scholar
  • 75 Maselli J H, Sontag M K, Norris J M, MacKenzie T, Wagener J S, Accurso F J. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.  Pediatr Pulmonol . 2003;  35 257-262
    CrossrefPubMedGoogle Scholar
  • 76 Ratjen F, Comes G, Paul K, Posselt H G, Wagner T O, Harms K. Effect of continuous antistaphylococcal therapy on the rate of P aeruginosa acquisition in patients with cystic fibrosis.  Pediatr Pulmonol . 2001;  31 13-16
    CrossrefPubMedGoogle Scholar
  • 77 Tummler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.  J Clin Microbiol . 1991;  29 1265-1267
    PubMedGoogle Scholar
  • 78 Kosorok M R, Jalaluddin M, Farrell P M. et al . Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.  Pediatr Pulmonol . 1998;  26 81-88
    CrossrefPubMedGoogle Scholar
  • 79 Farrell P M, Shen G, Splaingard M. et al . Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.  Pediatrics . 1997;  100 E2
    PubMedGoogle Scholar
  • 80 Hoiby N, Pedersen S S. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.  Acta Paediatr Scand . 1989;  78 395-404
    PubMedGoogle Scholar
  • 81 Pedersen S S, Jensen T, Pressler T, Hoiby N, Rosendal K. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?.  Acta Paediatr Scand . 1986;  75 840-845
    PubMedGoogle Scholar
  • 82 Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients.  Pediatr Infect Dis J . 1990;  9 494-498
    PubMedGoogle Scholar
  • 83 Armstrong D, Grimwood K, Carlin J B. et al . Severe viral respiratory infections in infants with cystic fibrosis.  Pediatr Pulmonol . 1998;  26 371-379
    PubMedGoogle Scholar
  • 84 LiPuma J J. Burkholderia cepacia: management issues and new insights.  Clin Chest Med . 1998;  19 473-486
    CrossrefPubMedGoogle Scholar
  • 85 Ledson M J, Gallagher M J, Jackson M, Hart C A, Walshaw M J. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.  Thorax . 2002;  57 142-145
    CrossrefPubMedGoogle Scholar
  • 86 McCloskey M, McCaughan J, Redmond A O, Elborn J S. Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.  Ir J Med Sci . 2001;  170 28-31
    PubMedGoogle Scholar
  • 87 Muhdi K, Edenborough F P, Gumery L. et al . Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.  Thorax . 1996;  51 374-377
    CrossrefPubMedGoogle Scholar
  • 88 Lewin L O, Byard P J, Davis P B. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.  J Clin Epidemiol . 1990;  43 125-131
    CrossrefPubMedGoogle Scholar
  • 89 Chen J S, Witzmann K A, Spilker T, Fink R J, LiPuma J J. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.  J Pediatr . 2001;  139 643-649
    CrossrefPubMedGoogle Scholar
  • 90 Govan J R, Brown P H, Maddison J. et al . Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.  Lancet . 1993;  342 15-19
    CrossrefPubMedGoogle Scholar
  • 91 Whiteford M L, Wilkinson J D, McColl J H. et al . Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.  Thorax . 1995;  50 1194-1198
    CrossrefPubMedGoogle Scholar
  • 92 Wang E E, Prober C G, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.  N Engl J Med . 1984;  311 1653-1658
    CrossrefPubMedGoogle Scholar
  • 93 Smyth A R, Smyth R L, Tong C Y, Hart C A, Heaf D P. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.  Arch Dis Child . 1995;  73 117-120
    CrossrefPubMedGoogle Scholar
  • 94 Hiatt P W, Grace S C, Kozinetz C A. et al . Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis.  Pediatrics . 1999;  103 619-626
    PubMedGoogle Scholar
  • 95 Collinson J, Nicholson K G, Cancio E. et al . Effects of upper respiratory tract infections in patients with cystic fibrosis.  Thorax . 1996;  51 1115-1122
    CrossrefPubMedGoogle Scholar
  • 96 Gardner G, Frank A L, Taber L H. Effects of social and family factors on viral respiratory infection and illness in the first year of life.  J Epidemiol Community Health . 1984;  38 42-48
    PubMedGoogle Scholar
  • 97 Bor D H, Epstein P R. Pathogenesis of respiratory infection in the disadvantaged.  Semin Respir Infect . 1991;  6 194-203
    PubMedGoogle Scholar
  • 98 Busse W W, Kiecolt-Glaser J K, Coe C, Martin R J, Weiss S T, Parker S R. NHLBI Workshop summary: stress and asthma.  Am J Respir Crit Care Med . 1995;  151 249-252
    PubMedGoogle Scholar
  • 99 Patterson J M, Budd J, Goetz D, Warwick W J. Family correlates of a 10-year pulmonary health trend in cystic fibrosis.  Pediatrics . 1993;  91 383-389
    PubMedGoogle Scholar
  • 100 Wallander J L, Varni J W. Adjustment in children with chronic physical disorders: programmatic research on a disability-stress-coping model. In: LaGreca AM, Siegal L, Wallander JL, Walker CE, eds. Stress and Coping in Child Health New York: Guilford Press 1992: 279-298
    Google Scholar
  • 101 Quittner A L, DiGirolamo A M, Michel M, Eigen H. Parental response to cystic fibrosis: a contextual analysis of the diagnosis phase.  J Pediatr Psychol . 1992;  17 683-704
    PubMedGoogle Scholar
  • 102 Wright R J, Steinbach S F. Violence: an unrecognized environmental exposure that may contribute to greater asthma morbidity in high risk inner-city populations.  Environ Health Perspect . 2001;  109 1085-1089
    PubMedGoogle Scholar
  • 103 Wright R J, Rodriguez M, Cohen S. Review of psychosocial stress and asthma: an integrated biopsychosocial approach.  Thorax . 1998;  53 1066-1074
    PubMedGoogle Scholar
  • 104 Quittner A L, DiGirolamo A M. Family adaptation to childhood disability and illness. In: Ammerman RT, Campo JV, eds. Handbook of Pediatric Psychology and Psychiatry Boston: Allyn & Bacon 1998: 70-102
    Google Scholar
  • 105 Patterson J M, McCubbin H I, Warwick W J. The impact of family functioning on health changes in children with cystic fibrosis.  Soc Sci Med . 1990;  31 159-164
    CrossrefPubMedGoogle Scholar
  • 106 Thompson R J, Gustafson K E, Hamlett K W, Spock A. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment.  J Pediatr Psychol . 1992;  17 741-755
    CrossrefPubMedGoogle Scholar
  • 107 Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis.  Curr Opin Pulm Med . 1996;  2 457-461
    PubMedGoogle Scholar
  • 108 Schoni M H, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review.  Clin Nutr . 2000;  19 79-85
    PubMedGoogle Scholar
  • 109 Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis.  J Pediatr . 1994;  124 244-249
    PubMedGoogle Scholar
  • 110 Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross-sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.  Thorax . 2002;  57 596-601
    CrossrefPubMedGoogle Scholar
  • 111 Konstan M W, Butler S M, Johnson C A, Wagener J S, Lai H C, Morgan W J. The relationship between nutritional status in early life and pulmonary function in cystic fibrosis.  Pediatr Pulmonol Suppl . 1999;  19 155-1156
    PubMedGoogle Scholar
  • 112 Walker S A, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings.  J Pediatr Gastroenterol Nutr . 1998;  27 53-56
    CrossrefPubMedGoogle Scholar
  • 113 James W P, Nelson M, Ralph A, Leather S. Socioeconomic determinants of health: the contribution of nutrition to inequalities in health.  BMJ . 1997;  314 1545-1549
    PubMedGoogle Scholar
  • 114 Kawchak D A, Zhao H, Scanlin T F, Tomezsko J L, Cnaan A, Stallings V A. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis.  J Pediatr . 1996;  129 119-129
    PubMedGoogle Scholar
  • 115 Marcus M S, Sondel S A, Farrell P M. et al . Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention.  Am J Clin Nutr . 1991;  54 578-585
    CrossrefPubMedGoogle Scholar
  • 116 Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis.  J Psychosom Res . 1999;  47 623-634
    CrossrefPubMedGoogle Scholar
  • 117 Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis.  Soc Sci Med . 2001;  53 1163-1174
    CrossrefPubMedGoogle Scholar
  • 118 Nixon P A, Orenstein D M, Kelsey S F, Doershuk C F. The prognostic value of exercise testing in patients with cystic fibrosis.  N Engl J Med . 1992;  327 1785-1788
    Google Scholar
  • 119 Orenstein D M, Nixon P A. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function.  Pediatr Pulmonol . 1991;  10 101-105
    PubMedGoogle Scholar
  • 120 Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis.  J Hum Nutr Diet . 2001;  14 83-91
    CrossrefPubMedGoogle Scholar
  • 121 Abbott J, Conway S, Etherington C. et al . Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers.  J Behav Med . 2000;  23 501-517
    CrossrefPubMedGoogle Scholar
  • 122 Truby H, Paxton A S. Body image and dieting behavior in cystic fibrosis.  Pediatrics . 2001;  107 E92
    CrossrefPubMedGoogle Scholar
  • 123 Lai H C, Kosorok M R, Laxova A, Makholm L M, Farrell P M. Delayed diagnosis of US females with cystic fibrosis.  Am J Epidemiol . 2002;  156 165-173
    CrossrefPubMedGoogle Scholar
  • 124 Braun L. Race, ethnicity, and health: can genetics explain disparities?.  Perspect Biol Med . 2002;  45 159-174
    PubMedGoogle Scholar
  • 125 Hamosh A, FitzSimmons S C, Macek Jr M, Knowles M R, Rosenstein B J, Cutting G R. Comparison of the clinical manifestation of cystic fibrosis in black and white patients.  J Pediatr . 1998;  132 255-259
    CrossrefPubMedGoogle Scholar
  • 126 Aligne C A, Auinger P, Byrd R S, Weitzman M. Risk factors for pediatric asthma: contributions of poverty, race, and urban residence.  Am J Respir Crit Care Med . 2000;  162 873-877
    PubMedGoogle Scholar
  • 127 Litonjua A A, Carey V J, Weiss S T, Gold D R. Race, socioeconomic factors, and area of residence are associated with asthma prevalence.  Pediatr Pulmonol . 1999;  28 394-401
    CrossrefPubMedGoogle Scholar
  • 128 Miller J E. The effects of race/ethnicity and income on early childhood asthma prevalence and health care use.  Am J Public Health . 2000;  90 428-430
    PubMedGoogle Scholar
  • 129 Persky V W, Slezak J, Contreras A. et al . Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children.  Ann Allergy Asthma Immunol . 1998;  81 266-271
    PubMedGoogle Scholar
  • 130 Corey M, McLaughlin F J, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.  J Clin Epidemiol . 1988;  41 583-591
    CrossrefPubMedGoogle Scholar
  • 131 Thomas J, Cook D J, Brooks D. Chest physical therapy management of patients with cystic fibrosis: a meta-analysis.  Am J Respir Crit Care Med . 1995;  151 846-850
    PubMedGoogle Scholar
  • 132 Fuchs H J, Borowitz D S, Christiansen D H. et al . Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.  N Engl J Med . 1994;  331 637-642
    CrossrefPubMedGoogle Scholar
  • 133 McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.  Chest . 1996;  110 889-895
    CrossrefPubMedGoogle Scholar
  • 134 Quan J M, Tiddens H A, Sy J P. et al . A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.  J Pediatr . 2001;  139 813-820
    CrossrefPubMedGoogle Scholar
  • 135 Ramsey B W, Pepe M S, Quan J M. et al . Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.  N Engl J Med . 1999;  340 23-30
    CrossrefPubMedGoogle Scholar
  • 136 Equi A, Balfour-Lynn I M, Bush A, Rosenthal M. Long-term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.  Lancet . 2002;  360 978-984
    CrossrefPubMedGoogle Scholar
  • 137 Frederiksen B, Lanng S, Koch C, Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.  Pediatr Pulmonol . 1996;  21 153-158
    CrossrefPubMedGoogle Scholar
  • 138 Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.  Pediatr Pulmonol . 1997;  23 330-335
    CrossrefPubMedGoogle Scholar
  • 139 Rosenecker J, Hofler R, Steinkamp G. et al . Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome.  Eur J Med Res . 2001;  6 345-350
    PubMedGoogle Scholar
  • 140 Aris R M, Lester G E, Renner J B. et al . Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation.  Am J Respir Crit Care Med . 2000;  162 941-946
    CrossrefPubMedGoogle Scholar
  • 141 Colombo C, Battezzati P M, Crosignani A. et al . Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome.  Hepatology . 2002;  36 1374-1382
    CrossrefPubMedGoogle Scholar
  • 142 Subcommittee TCFFCCaG. Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers.  Am J Dis Child . 1990;  144 1311-1312
    PubMedGoogle Scholar
  • 143 Collins C E, MacDonald-Wicks L, Rowe S, O'Loughlin E V, Henry R L. Normal growth in cystic fibrosis associated with a specialised centre.  Arch Dis Child . 1999;  81 241-246
    PubMedGoogle Scholar
  • 144 Mahadeva R, Webb K, Westerbeek R C. et al . Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross-sectional study.  BMJ . 1998;  316 1771-1775
    PubMedGoogle Scholar
  • 145 Adler N E, Boyce W T, Chesney M A, Folkman S, Syme S I. Socioeconomic inequalities in health.  JAMA . 1993;  269 3140-3145
    CrossrefPubMedGoogle Scholar
  • 146 Curtis J R, Burke W, Kassner A, Aitkin M L. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis.  Am J Respir Crit Care Med . 1997;  155 1921-1924
    PubMedGoogle Scholar
  • 147 Hahn B, Flood A B. No insurance, public insurance, and private insurance: do these options contribute to differences in general health?.  J Health Care Poor Underserved . 1995;  6 41-59
    PubMedGoogle Scholar
  • 148 Henley L D, Hill I D. Errors, gaps, and misconceptions in the disease-related knowledge of cystic fibrosis patients and their families.  Pediatrics . 1990;  85 1008-1014
    PubMedGoogle Scholar
  • 149 Henley L D, Hill I D. Global and specific disease-related information needs of cystic fibrosis patients and their families.  Pediatrics . 1990;  85 1015-1021
    PubMedGoogle Scholar
  • 150 Konstan M W, Butler S M, Schidlow D V, Morgan W J, Julius J R, Johnson C A. Patterns of medical practice in cystic fibrosis, II: Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.  Pediatr Pulmonol . 1999;  28 248-254
    CrossrefPubMedGoogle Scholar
  • 151 Konstan M W, Butler S M, Schidlow D V, Morgan W J, Julius J R, Johnson C A. Patterns of medical practice in cystic fibrosis, I: Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.  Pediatr Pulmonol . 1999;  28 242-247
    CrossrefPubMedGoogle Scholar
  • 152 Abbott J, Dodd M, Webb A K. Health perceptions and treatment adherence in adults with cystic fibrosis.  Thorax . 1996;  51 1233-1238
    PubMedGoogle Scholar
  • 153 Conway S P, Pond M N, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis.  Thorax . 1996;  51 29-33
    PubMedGoogle Scholar
  • 154 Quittner A L, Espelage D L, Ievers-Landis C, Drotar D. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information.  J Clin Psychol Med Settings . 2000;  7 41-54
    CrossrefPubMedGoogle Scholar
  • 155 Greenberg R N. Overview of patient compliance with medication dosing: a literature review.  Clin Ther . 1984;  6 592-599
    PubMedGoogle Scholar
  • 156 Lask B. Nonadherence to treatment in cystic fibrosis.  J R Soc Med . 1994;  87 25-27
    PubMedGoogle Scholar
  • 157 Koocher G P, McGrath M L, Gudas L J. Typologies of nonadherence in cystic fibrosis.  J Dev Behav Pediatr . 1990;  11 353-358
    PubMedGoogle Scholar
  • 158 Gudas L J, Koocher G P, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis.  J Dev Behav Pediatr . 1991;  12 236-242
    PubMedGoogle Scholar
  • 159 DiMatteo M R. Enhancing patient adherence to medical recommendations.  JAMA . 1994;  271 79-82
    CrossrefPubMedGoogle Scholar
  • 160 Eddy M E, Carter B D, Kronenberger W G. et al . Parent relationships and compliance in cystic fibrosis.  J Pediatr Health Care . 1998;  12 196-202
    CrossrefPubMedGoogle Scholar
  • 161 Ievers C E, Brown R T, Drotar D, Caplan D, Pishevar B S, Lambert R G. Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers.  J Dev Behav Pediatr . 1999;  20 335-343
    PubMedGoogle Scholar
  • 162 Quittner A L, Drotar D, Ievers-Landis C, Seidner D, Slocum N, Jacobsen J. Adherence to medical teatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions. In: Drotar D, ed. Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Concepts, Methods, and Interventions Mahwah, NJ: Erlbaum Associates; 2000: 383-407
    Google Scholar
  • 163 Clinical Practice Guidelines for Cystic Fibrosis Committee. Clinical Practice Guidelines for Cystic Fibrosis.  Bethesda: Cystic Fibrosis Foundation; 1997
    Google Scholar
  • 164 Schechter M S. Demographic and Center-Related Characteristics Associated with Low Weight in Pediatric CF Patients.  Pediatric Pulmonology . 2002;  suppl 22 156-157
    PubMedGoogle Scholar
  • 165 Berwick D M. Continuous improvement as an ideal in health care.  N Engl J Med . 1989;  320 53-56
    PubMedGoogle Scholar
  • 166 Institute of Medicine Committee on Quality Health Care in America. Crossing the quality chasm: a new health system for the 21st century.  Washington, DC: National Academy Press 2001
    Google Scholar